1. Role: Department Vice-Chair. Scope: Department. Date: 2021.
Jamie L. Miller, Pharm.D., BCPS, BCPPS, FPPAG
Prof
Pharmacy Clinical & Admin Sci
Phone (405) 271-6878 x47296
Office COP300
Email jamie-miller@ou.edu
Publications & Presentations
- 36. Bennett K, Fox A, Miller J, Neely S, Dennis V C, Johnson P. Publication Rates of Pharmacy Residents Involved in a Team-Based Research Program. American Journal of Health-System Pharmacy. 2022; 79 : 2141-2149
37. Mayes R A, Johnson P N, White B P, Neely S, Chaaban H, Miller J L. Impact of Ceftazidime Use on Susceptibility Patterns in a Neonatal Intensive Care Unit: A 7.5-year Evaluation. Journal of the Pediatric Infectious Diseases Society. 2022; 11 : 349-350
38. Lim S Y, May C B, Johnson P N, Miller J L. Caffeine dosing in premature neonates: impact of birth weight on a pharmacokinetic simulation study. Pediatric research. 2022
39. Taher K W, Johnson P N, Miller J L, Neely S, Gupta N. Efficacy and Safety of Prolonged Magnesium Sulfate Infusions in Children With Refractory Status Asthmaticus. Frontiers in pediatrics. 2022; 10 : 860921
40. Bobo K S, Cober M P, Eiland L S, Heigham M, King M, Johnson P N, Miller J L, Sierra C M. Correction to: Key articles and guidelines for the pediatric clinical pharmacist from 2019 and 2020. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 2022; 79 : 823
Grants
- 1. Selenium Pharmacokinetics and Pharmacodynamics of Infants with Intestinal Failure a Prospective Cohort Study. Misc Non-Federal. Start Date: 2025. End Date: 2026.
2. Evaluation of caffeine dosing regimens and the impact of developmental pharmacokinetics in neonates with apnea of prematurity. Misc Non-Federal. Start Date: 2020. End Date: 2021.
3. Characterization of fentanyl metabolic and renal elimination pathways in children less than two years of age. Misc Non-Federal. Start Date: 2018. End Date: 2020.
4. Development of a dose-exposure response relationship for detection of opioid tolerance in critically-ill children receiving fentanyl continuous infusions. Misc Non-Federal. Start Date: 2015. End Date: 2017.
5. Development of a dose-exposure response relationship for detection of opioid tolerance in critically-ill children receiving fentanyl continuous infusions. Misc Non-Federal. Start Date: 2015. End Date: 2017.
Awards and Honors
- 11. Oklahoma Residency Research Conference. Oklahoma Research Excellence Award (Mentor). Date: 2019.
12. Rho Chi, Gamma Chapter. 2019 Chapter Alumni Award. Date: 2019.
13. Oklahoma Society of Health-System Pharmacists. Oklahoma Pharmacist of the Year. Date: 2019.
14. University of Oklahoma College of Pharmacy; Department of Clinical and Administrative Sciences. Best Paper Award. Date: 2018.
15. Pediatric Pharmacy Association. Fellow of Pediatric Pharmacy Association. Date: 2018.
Education
- 1. Degree: PharmD. Southwestern Oklahoma State University. Date: 2006.
2. Degree: BS. Trevecca Nazarene University. Date: 2002.